Skip to main content
. 2016 Oct 4;11(10):e0164204. doi: 10.1371/journal.pone.0164204

Fig 1. A conceptual framework including determinants that might affect cognitive impairment in chemotherapy-treated breast cancer patients.

Fig 1

This study was performed to evaluate the downstream effects of TNF-308 and IL6-174 polymorphisms on the circulating TNF-α and IL-6 levels, and the occurrence of chemotherapy-associated cognitive impairment.